PRESCRIPTION DRUG "REMINDER AD" AND PREAPPROVAL AD POLICIES ARE BEING RE-EVALUATED BY FDA; AGENCY HAS ISSUED 10 TO 15 LETTERS FOR VIOLATIVE REMINDER ADS

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".